Search Results 301-310 of 17282 for SC

  1. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    View all physicians • All Locations · Camilleri, Michael M.D., D.Sc. Minnesota · DiBaise, John K. M.D.. Arizona · Farrugia, Gianrico M.D.. Minnesota · Fox, Jean ...

  2. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    ... (SC) injection every 4th week in patients with relapsing or refractory EGPA on corticosteroid therapy with or without stable immunosuppressive therapy. All ...

  3. Collaborators - Cellular and Molecular Physiology of Gastrointestinal Disorders Laboratory - Mayo Clinic Research

    Georgine Faulkner, Ph.D. International Centre for Genetic Engineering and Biotechnology Trieste, Italy; Braden Kuo, M.D., M.Sc. Massachusetts General Hospital

  4. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA) - Mayo Clinic

    The primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab ...

  5. Oncology (Medical) - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  6. Iga Nephropathy (Berger Disease) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in ...

  7. Multisystem inflammatory syndrome in children (MIS-C) and COVID-19 - Symptoms and causes - Mayo Clinic

    Aronoff SC, et al. The natural history of severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children (MIS-C): A ...

  8. Melanoma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...

  9. Mayo Clinic Hospital, Methodist Campus

    SC: Mayo Clinic Breadcrumb. Patient & Visitor Guide · Mayo Clinic in Rochester, Minnesota · Campus buildings & maps. Sections Campus buildings & maps. Getting ...

  10. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    Camilleri, Michael M.D., D.Sc. camilleri.michael@mayo.edu; Professor of Medicine; Professor of Pharmacology; Professor of Physiology · Chini, Eduardo N. M.D., Ph ...